A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 336
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PF
Long Form : pulmonary fibrosis
No. Year Title Co-occurring Abbreviation
2020 A new FGFR inhibitor disrupts the TGF-beta1-induced fibrotic process. TGF
2020 Adipose Tissue-Derived Mesenchymal Stem Cells Protect Against Amiodarone-Induced Lung Injury in Rats. adMSC, alpha-SMA, AMD, CC16, CK19, FGF7, MSCs
2020 CD4+CD25+ Tregs as dependent factor in the course of bleomycin-induced pulmonary fibrosis in mice. ---
2020 Grp78 Loss in Epithelial Progenitors Reveals an Age-linked Role for Endoplasmic Reticulum Stress in Pulmonary Fibrosis. AEC, ER, IPF, KO, TMX
2020 Lipopolysaccharide induces epithelial-mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway. Col1, EMT, IL, JAK2, LPS, MMP, STAT3, TGF, THP-1
2020 Microenvironment-Responsive Small-Molecule Probe for Pulmonary Fibrosis Detection. NO
2020 Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats. BALF, BLM, CAT, FO, SOD, TGFbeta
2019 A novel mutation causes Hermansky-Pudlak syndrome type 4 with pulmonary fibrosis in 2 siblings from China. HPS, HPS-4, OCA
2019 AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis. AAV1, BLM, FOXM1, IL-6, NF-kappaB, OTUB1, SERCA2a, Smad, STAT3
10  2019 Activation of PERK in ET-1- and thrombin-induced pulmonary fibroblast differentiation: Inhibitory effects of curcumin. alpha-SMA, CCN2, Col I, CUR, ER, ET-1, IHC, JNK, PERK, siRNA, TG
11  2019 Alpha-Mangostin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice Partly Through Activating Adenosine 5'-Monophosphate-Activated Protein Kinase. alpha-MG, alpha-SMA, AMPK, BLM, Col I, ECM, NDN, NOX4, PLFs
12  2019 An animal research and a chemical composition analysis of a Chinese prescription for pulmonary fibrosis: Yangfei Huoxue Decoction. AM, BLM, EA, GL, LX, RJ, SB, SC, YHD
13  2019 Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis. CQ, HLF, YFSJF
14  2019 Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosis. AECs, cAMP, SiNPs
15  2019 Bleeding assessment in female patients with the Hermansky-Pudlak syndrome-A case series. BS, HPS, ISTH-BAT, PPH
16  2019 Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3epsilon as potential biomarkers. ---
17  2019 Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary Hypertension. CP, PH, SSc
18  2019 Clinical quantification of the integrin alphavbeta6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). CTD, IPF, PETAL Study, SUV, TGF-beta, VT
19  2019 Combination of L-Arginine and L-Norvaline protects against pulmonary fibrosis progression induced by bleomycin in mice. Arg, BLM, Cit, L-Arg, L-Nor, Orn, Pro
20  2019 COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence. AECs, ARA, BLM, sEH
21  2019 CXCL16 Induces the Progression of Pulmonary Fibrosis through Promoting the Phosphorylation of STAT3. LPS, p-STAT3
22  2019 Dexamethasone combined with berberine is an effective therapy for bleomycin-induced pulmonary fibrosis in rats. alpha-SMA, BBR, BLM, CXCL14, CXCR4, Dxs, Hyp, MMP
23  2019 Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF. BLM, EMT, HMGB1, Nrf2, TGF-beta1, WT
24  2019 Efficacy of pirfenidone for the treatment of pulmonary fibrosis: An updated systematic review protocol of randomized controlled trial. ---
25  2019 Expression of TRB3 promotes epithelial‑mesenchymal transition of MLE‑12 murine alveolar type II epithelial cells through the TGF‑beta1/Smad3 signaling pathway. EMT, TRB3
26  2019 Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts. ECM, FBP, FLF, MMP, TIMP
27  2019 Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey. EU-IPFF, HCPs, IPF
28  2019 Glycogen Synthase Kinase-3beta Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis. IPF, p-Y216
29  2019 IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. SSc
30  2019 Immediate Release of Gastrin-Releasing Peptide Mediates Delayed Radiation-Induced Pulmonary Fibrosis. GRP, RT, RTPF
31  2019 Inhibition of the TGF-beta/Smads signaling pathway attenuates pulmonary fibrosis and induces anti-proliferative effect on synovial fibroblasts in rheumatoid arthritis. HE, RA, RASF
32  2019 Interleukin-18 promotes fibroblast senescence in pulmonary fibrosis through down-regulating Klotho expression. BLM, IL-18BP, IPF, SASP
33  2019 Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation. BLM
34  2019 Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: possible role in inhibiting TGF-beta1-induced epithelial-mesenchymal transition through ERK pathway. BALF, ELISA, EMT, ERK, LMWF, TGF-beta1
35  2019 Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. AR, CLAD, HR
36  2019 microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model. DEGs, miRs
37  2019 miR-205 Suppresses Pulmonary Fibrosis By Targeting GATA3 Through Inhibition Of Endoplasmic Reticulum Stress. BLM
38  2019 miR-627/HMGB1/NF-kappaB regulatory loop modulates TGF-beta1-induced pulmonary fibrosis. alpha-SMA, HMGB1
39  2019 Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition. alpha-SMA, BLM, E-cad, EMT, IL, IL-18BP, IPF, TGF-beta1
40  2019 Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway. ILD, MF, MPO, NET, PM
41  2019 Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/beta-catenin signaling: A drug repurposing study. ---
42  2019 Oral Administration of Chitosan Attenuates Bleomycin-induced Pulmonary Fibrosis in Rats. BALF, BLM, IFN, TGF
43  2019 P27 Promotes TGF-beta-Mediated Pulmonary Fibrosis via Interacting with MTORC2. ILD, IPF
44  2019 Patient outcomes from time of listing for lung transplantation in the UK: are there disease-specific differences? CF
45  2019 Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-beta/smad signaling pathway. BLM, ECM, EMT
46  2019 PM2.5 induced pulmonary fibrosis in vivo and in vitro. alpha-SMA, EMT, HE, PM2.5, TGF-beta1
47  2019 Protective and anti-inflammatory effect of selenium nano-particles against bleomycin-induced pulmonary injury in male rats. SeNPs, TGF-beta1, TNF-alpha
48  2019 Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-beta/MAPK signaling pathway and oxidative stress. NOX4, ROS, TGF-beta1
49  2019 Protective Effect of the Traditional Chinese Patent Medicine Qing-Xuan Granule against Bleomycin-Induced Pulmonary Fibrosis in Mice. QX
50  2019 Pulmonary Fibrosis among World Trade Center Responders: Results from the WTC Health Registry Cohort. aHR, WTC
51  2019 Pulmonary Fibrosis in Children. ---
52  2019 Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly. BLM, HUMSCs, MMP-9, TLR4
53  2019 Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage, and pulmonary fibrosis. IPF, mt, PA, PLD
54  2019 S-Allylmercaptocysteine attenuates Bleomycin-induced pulmonary fibrosis in mice via suppressing TGF-beta1/Smad and oxidative stress pathways. BALF, BLM, Hyp, SAMC
55  2019 Salvia miltiorrhiza Restrains Reactive Oxygen Species-Associated Pulmonary Fibrosis via Targeting Nrf2-Nox4 Redox Balance. BLM, EASM, Keap1, NOX4, Nrf2, PKCdelta, ROS, TGF-beta1
56  2019 Tanshinone IIA Activates Nuclear Factor-Erythroid 2-Related Factor 2 to Restrain Pulmonary Fibrosis via Regulation of Redox Homeostasis and Glutaminolysis. BLM, Keap1, Nrf2, PKCdelta, ROS, Tan IIA
57  2019 Targeting Degradation of the Transcription Factor C/EBPbeta Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages. AMs, GSK-3beta
58  2019 Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis. AECs, EMT, IPF, TGF-beta1, TSPAN1
59  2019 The effects of atorvastatin on the kidney injury in mice with pulmonary fibrosis. ---
60  2019 The effects of phycocyanin on bleomycin-induced pulmonary fibrosis and the intestinal microbiota in C57BL/6 mice. HE, IL-1beta, LPS, PC, TNF-alpha
61  2019 Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model. OCA, Pao
62  2019 Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-beta/Smad signaling pathways in vivo and in vitro. alpha-SMA, BLM, FN, Hyp, MV, PEF, XJXBCQ
63  2019 Transcriptome network analysis identifies protective role of the LXR/SREBP-1c axis in murine pulmonary fibrosis. IPF
64  2019 Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement. AAV, ANCA, GPA, ILD, LUS, MPA
65  2018 A novel molecular mechanism of microRNA-21 inducing pulmonary fibrosis and human pulmonary fibroblast extracellular matrix through transforming growth factor beta1-mediated SMADs activation. BLM, ECM, miR, TGF-beta1, TGFbeta1RI
66  2018 Activated human T lymphocytes inhibit TGFbeta-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2. ---
67  2018 Airway transplantation of adipose stem cells protects against bleomycin-induced pulmonary fibrosis. ADSC, BLM, IPF
68  2018 An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines. ECM, EMT
69  2018 Andrographolide ameliorates silica induced pulmonary fibrosis. BALF, EMT, HD, LD, LDH
70  2018 Asiatic acid prevents the development of interstitial lung disease in a hypochlorous acid-induced mouse model of scleroderma. AA, HOCl, SSc, TGF-beta1
71  2018 Associations of Pulmonary Fibrosis with Peripheral Blood Th1/Th2 Cell Imbalance and EBF3 Gene Methylation in Uygur Pigeon Breeder's Lung Patients. PBL
72  2018 Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat. BALF, PQ, SOD
73  2018 Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells. ALI, BLM, MTT
74  2018 Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series). CLD, COPD, MPC
75  2018 Effects of formaldehyde exposure on the development of pulmonary fibrosis induced by bleomycin in mice. CXCL1, FA, TNF-alpha
76  2018 Effects of panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits. AST, CK, FN, Hyp, IL-6, IL-8, LDH, PNS
77  2018 FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro. BLM, FGF21, PFD, PQ
78  2018 Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway. alpha-SMA, ERK, FSTL1, JNK, MAPK, MLgs, TGF-beta1, WT
79  2018 Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice. alpha-SMA, HMGB1, PBS
80  2018 Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process. BLM, GPS
81  2018 HIF-1alpha triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis. AECs, CHOP, ER, HIF-1alpha, IPF, UPR
82  2018 Hypoxia-inducible factor-1alpha regulates epithelial-to-mesenchymal transition in paraquat-induced pulmonary fibrosis by activating lysyl oxidase. EMT, HIF-1alpha, LOX, PQ
83  2018 Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: Literature review. CTC, HRCT, ILD, RA
84  2018 Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-beta1/Smad pathway. CM, iPSCs, TGF-beta1
85  2018 KLF2 attenuates bleomycin-induced pulmonary fibrosis and inflammation with regulation of AP-1. AP-1, BALF, BLM, col1a1, HE, KLF2
86  2018 Left Single Lung Transplantation Through Left Anterolateral Thoracotomy With Longitudinal Partial Sternotomy (Hemiclamshell): An Innovative Surgical Resource. HCS
87  2018 MicroRNA-30d/JAG1 axis modulates pulmonary fibrosis through Notch signaling pathway. ECM, NHLF
88  2018 NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis. BLM, BM-MSCs, Glu, NMDA
89  2018 Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis. BLM, EMT, HO-1, NQO1, Nrf2, PTB, SFN, TGF-beta1, WT
90  2018 Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-gamma and subsequent expression of HGF in colons. ---
91  2018 Oropharyngeal administration of silica in Swiss mice: A robust and reproducible model of occupational pulmonary fibrosis. ---
92  2018 Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-kappaB/Snail signaling pathway. BLM, EMT, IPF, PTL
93  2018 Protective effect of standardized extract of Myrtus communis L. (myrtle) on experimentally bleomycin-induced pulmonary fibrosis: biochemical and histopathological study. BLM, i.p, IPF, mPRED
94  2018 Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis. siPAI-1
95  2018 Regulation of Transforming Growth Factor-beta/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis. BLM, EMT, Hsp90, TGF-beta
96  2018 Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways. BLM, RES
97  2018 SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice. BLM
98  2018 The association between transforming growth factor beta1 polymorphism and susceptibility to pulmonary fibrosis: A meta-analysis (MOOSE compliant). CIs, ORs, SNPs, TGF-beta1
99  2018 The Inhibitory Effects of Cyclodepsipeptides from the Entomopathogenic Fungus Beauveria bassiana on Myofibroblast Differentiation in A549 Alveolar Epithelial Cells. ECM
100  2018 Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells. alpha-SMA, BMSCs, Col I, Col III, EMT, SIS3, TGF-beta1